Compliance

Policy register

The following policies are adopted by the Board of Directors and binding on everyone acting for PHARMEQ AG. They are reviewed at least annually.

Doc. no.DocumentStatus

PQ-COM-01Code of ConductThe binding ground rules for the conduct of all employees and corporate bodies of PHARMEQ AG.Rev. 2026-01

PQ-COM-02Compliance PolicyHow compliance is organised at PHARMEQ AG: responsibilities, controls, reporting channels.Rev. 2026-01

PQ-COM-03Anti-Corruption and Anti-Bribery PolicyZero tolerance of bribery – with clear limits for gifts, invitations and sponsoring.Rev. 2026-01

PQ-COM-04Conflicts of Interest PolicyWhen a conflict of interest exists, how it is reported and how it is to be handled in resolutions.Rev. 2026-01

PQ-COM-05Outside Activities Policy for the Board of Directors and Executive ManagementOutside activities and shareholdings of members of the corporate bodies are subject to approval and disclosure.Rev. 2026-01

PQ-COM-06Whistleblowing PolicyHow misconduct can be reported and how reporting persons are protected.Rev. 2026-01

PQ-COM-07Sanctions and Export Control PolicyScreening obligations before every cross-border delivery and when dealing with new business partners.Rev. 2026-01

PQ-COM-08Supplier CodeWhat we expect from our suppliers – a precondition for every business relationship.Rev. 2026-01

PQ-COM-09Human Rights and Sustainability StatementOur position on human rights, the environment and responsibility in the supply chain.Rev. 2026-01

PQ-COM-10Quality PrinciplesHow we ensure product quality, documentation and traceability in trading.Rev. 2026-01

PQ-COM-11Information Security PolicyMinimum requirements for the handling of systems, access rights and data.Rev. 2026-01

Questions on a policy, or reports under PQ-COM-06, should be addressed to the management.

These policies describe the internal order of PHARMEQ AG. They create no third-party entitlements and do not replace any contractual agreement.